Vitiligo and Psychodrama Therapy
Key facts
- Who runs it
- Azienda Sanitaria Universitaria Integrata del Trentino
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 7 people enrolled
- Started
- 2 Nov 2023
- Ended
- 11 May 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Psychodramatic psychotherapy
- Self-help activities
- Record updated
- 20 June 2024
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Segmental vitiligo with unilateral localization
- Non-segmental vitiligo (acrofacial; mucosal with more than one side affected; generalized universal; mixed associated with segmental vitiligo)
- Vitiligo-associated autoimmune comorbidity referred to in points 1-2: Thyroiditis
- Symptoms of depression and/or anxiety and/or low self-esteem associated with Vitiligo mentioned in points 1-2
Who cannot take part
- Have previously received other psychotherapy
- Cognitive impairment/dementia (clinically diagnosed)
- Use of psychiatric drugs in the last 3 months
- Individual and/or group psychotherapy in progress
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this pilot clinical trial is to assess the effectiveness of psychodramatic psychotherapy in reducing the psychological distress and/or the skin condition in patients with vitiligo.
Read full original descriptionShow less
The main questions it aims to answer are:
1. Is there any improvement in terms of psychological distress in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? 2. Is there any improvement in terms of skin condition in patients with vitiligo participating in a psychodramatic psychotherapy, compared to a control group? Participants in the experimental group will receive the dermatological drug treatment usually recommended for vitiligo, and in addition they will participate in a 6 months psychodramatic psychotherapy.
Researchers will compare the results of the experimental group with the results of a control group including vitiligo patients who will receive the dermatological pharmacological treatment usually recommended for vitiligo and participate in a 6 months program of self-help activities.
The 2 groups in the trial
- Psychodramatic PsychotherapyTreatment being tested
This experimental arm will include 12 patients with vitiligo (randomly assigned to this arm), attending the dermatology services of APSS Trento. This experimental group will receive the drug treatment usually recommended for vitiligo, in addition to 6 months of psychodramatic psychotherapy.
- Self-help activitiesExisting treatment, for comparison
This is a control arm which will include 12 patients with vitiligo (randomly assigned to this arm), attending the dermatology services of APSS Trento. This control group will receive the drug treatment usually recommended for vitiligo, in addition to 6 months of self-help activities.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Vitiligo and Psychological Distress: Pilot Study for the Experimentation of a Psychodramatic Psychotherapy Treatment
- Record updated
- 20 June 2024